L) and Theravance (NasdaqGS:THRX) on Thursday jointly announced the US Food and Drug Administration's (FDA) approval of BREO
ELLIPTA (fluticasone furoate/vilanterol [FF/VI]) for the once-daily treatment of adults patients with asthma, a chronic lung disease that inflames and narrows the airways.
This supplemental New Drug Application (NDA) 204275-S001 for the company's fluticasone furoate and vilanterol dry powder for inhalation (with the brand name of BREO
ELLIPTA) and sponsored by Glaxo Group is being reviewed for the once-daily treatment for asthma in patients aged 12 years and older.
3 billion, while BREO
Ellipta, a new combination treatment co-developed with Theravance, could become the successor to Advair.
L)(NYSE: GSK) and biopharmaceutical company Theravance Inc (Nasdaq:THRX) announced on Wednesday the availability of BREO
ELLIPTA, a once-daily prescription medicine for chronic obstructive pulmonary disease (COPD), in pharmacies throughout the US.
ELLIPTA is a combination of the inhaled corticosteroid (ICS), fluticasone furoate FF , and the long-acting beta2 agonist (LABA), vilanterol VI (FF/VI 100/25 mcg).
L) and Theravance Inc (NasdaqGS:THRX) jointly stated on Wednesday that the US Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) have voted in favour of the approval of BREO
ELLIPTA for chronic obstructive pulmonary disease (COPD).
ANORO , RELVAR , BREO
and ELLIPTA are trademarks of the GlaxoSmithKline group of companies.
ELLIPTA , is the proposed proprietary name for FF/VI 100/25 mcg, a combination of the inhaled corticosteroid (ICS) fluticasone furoate FF and the long acting bronchodilator (LABA) vilanterol VI (FF/VI).
Where: Parc le Breos House, Parkmill, Gower SA3 2HA
George Neal submitted a photo of a helicopter taking off from Parc Le Breos in Wales.
Roedd Grandma a Grandpa yn arweinwyr y Sgowtiaid ym Mharc le Breos lawr ym Mae Tri Chlogwyn ar Benrhyn Gwyr, felly bob dydd Sadwrn yn yr haf ro''n i allan gyda nhw yn dringo, yn cynnau tan, gosod pebyll ac yn chwilio am fywyd gwyllt, trychfilod ac olion mamaliaid,meddai ef.
Compelling evidence of excarnation in Britain comes not from caves but from Neolithic long cairns at Ascott under Wychwood, Oxfordshire and Parc le Breos Cwm on the Gower Peninsula.